Market revenue in 2022 | USD 30.8 million |
Market revenue in 2030 | USD 192.9 million |
Growth rate | 25.8% (CAGR from 2022 to 2030) |
Largest segment | Pregnancy and postpartum general anxiety |
Fastest growing segment | Postpartum Depression |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD |
Key market players worldwide | Canopy Growth Corp, Pfizer Inc, Viatris Inc, GlaxoSmithKline, Mallinckrodt PLC Ordinary Shares - New, Bausch Health Companies Inc, Sage Therapeutics Inc, Centene Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to maternal mental health will help companies and investors design strategic landscapes.
Pregnancy and postpartum general anxiety was the largest segment with a revenue share of 34.74% in 2022. Horizon Databook has segmented the UAE maternal mental health based on postpartum depression, dysthymia, pregnancy and postpartum general anxiety, pregnancy and postpartum ocd, birth-related ptsd covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE maternal mental health, including forecasts for subscribers. This country databook contains high-level insights into UAE maternal mental health from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account